Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome.

Wei Sheng, Guang Ji, Li Zhang

Journal: World journal of gastroenterology 2022;28(43):6099-6108

PMID: 36483151

Free Full Text on Baishideng Publishing Group Inc. View on PubMed

Abstract

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with sleep apnea syndrome (SAS). Many NAFLD patients have SAS, and obstructive sleep apnea hypopnea syndrome is also considered to be an independent risk factor for NAFLD, as it contributes to the progression of NAFLD oxidative stress, lipid peroxidation, inflammation, and insulin resistance. This review aims to provide some recommendations for the management of NAFLD patients with SAS, including diet, exercise, weight loss, and continuous positive airway pressure. This review also highlights the importance of effective strategies in NAFLD prevention and treatment.

Address: Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.; Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China. [email protected].

DOI: 10.3748/wjg.v28.i43.6099

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/sleepapnea.html

MeSH Terms: Humans, Non-alcoholic Fatty Liver Disease, Sleep Apnea Syndromes